10x Genomics, Inc.今日盘中股价大涨5.13%,引发市场关注。据报道,多家券商分析师下调了该公司的目标股价,这可能是导致股价上涨的主要原因。
摩根大通、杰富瑞和德意志银行等知名投行均下调了10x Genomics的目标股价。摩根大通将目标价从20美元下调至14美元,杰富瑞则从24美元下调至23美元,德意志银行则从25美元下调至16美元。分析师普遍认为,10x Genomics的业务增长将放缓,未来几个季度的财务表现可能不及预期。
不过,即便如此,仍有分析师维持对该公司的乐观态度。鉴于其在单细胞测序领域的领先地位,有分析师认为10x Genomics长期前景依然看好。只是在当前经济环境下,业绩增长或将放缓。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.